Polymorphous Light Eruption
From Anvita Health Wiki
Contents |
More Specific Terms
Introduction
- A group of heterogenous, idiopathic, acquired, acute & recurrent photodermatoses characterized by delayed skin reactions to UV radiation.
Etiology
- precipitated most frequently by exposure to UV-A, but also UV-B or by both
- since UV-A is transmitted through glass, PMLE may be preciptated while driving or riding in a motor vehicle
- appears to be a threshold for elicitation of PMLE
- may be delayed hypersensitivity reaction to antigen induced by UV radiation
Epidemiology
- average age of onset is 23 years
- most common of the photodermatoses
- all races
- much more common in females
- less frequently observed in sunbelt (year-round sun)
- often occurs for 1st time in individuals traveling for short vacations to the tropics in winter from northern latitudes
- occurs in spring & early summer in temperate zones
Pathology
- edema of the epidermis
- basal layer with spongiosis, vesicle formation & mild liquifaction degeneration
- no thickening or atrophy of the basement membrane
- dense lymphocytic ( T-cell) infiltrate in the dermis
- occasional neutrophils in the dermis
- edema of the papillary dermis
- endothelial swelling
- direct immunofluorescence for IgG is negative Clinical manifestions:
- monomorphous reaction consisting of macules, papules, plaques or vesicles ( papular & papulovesicular eruptions are most common)
- lesions are pink to red
- rash occurs suddenly after hours to days of sun exposure
- most frequently appears within 18-24 hours of exposure
- persists for 7-10 days
- areas of skin habitually exposed (face & neck) may be spared despite severe involvement of trunk & extremities
- pruritis & paresthesia may precede the rash
- chronic & recurrent disorder, may become worse each season
- patients may develop a tolerance by the end of summer, but generally recurs the following season
- spontaneous improvement or resolution generally occurs after several years
Laboratory
- serology: anti-nuclear antibody ( ANA) 3-19% [2]
- complete blood count ( CBC): no leukopenia
- biopsy (if plaque-type lesions)
- phototesting with UV-A & UV-B
Complications
- ANA+ PMLE does NOT transform to lupus [2]
Differential-diagnosis
- lupus erythematosus ( plaque-type lesions)
- drug reaction
- allergic reaction to cosmetic
Management
-
- beta carotene not very effective, but may be tried
- hydroxychloroquine 200 mg PO BID
- one day before & daily while vacationing or on weekends in the sun
- effective in some patients
- use in patients not helped by sunscreens or beta-carotene
- PUVA photochemotherapy
- given in early spring induces tolerance for the following summer
- treatments 3 times weekly for 4 weeks
- repeat each spring for 3-4 years
More General Terms
Additional Terms
- beta-carotene
- hydroxychloroquine (Plaquenil)
- oral psoralen & ultraviolet (UV) A light (PUVA)
- paresthesia
- pruritis (itching)
- UV-A radiation
- UV-B radiation
References
- Color Atlas & Synopsis of Clinical Dermatology, Common & Serious Diseases, 3rd ed, Fitzpatrick et al, McGraw Hill, NY, 1997, pg 250-53
- Tzaneva S et al Antinuclear antibodies in patients with polymorphic light eruption: a long-term follow-up study. Br J Dermatol. 2008 May;158(5):1050-4. Epub 2008 Mar 13. PMID: [1]
